Vanda Pharmaceuticals Inc (VNDA)
R&D Expense Growth
29.96%
Quarterly · Period ending:
VNDA R&D Expense Growth
Latest reported29.96%period ending
Latest reported29.96%period ending
VNDA Quarterly R&D Growth (QoQ) (0.00% → 29.96%)
Latest values, visible window
High-resolution chart · PNG
VNDA r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 29.956% | |
| -1.9686% | |
| 28.5556% | |
| 2.6057% | |
| -38.4241% | |
| 80% | |
| 18.2642% | |
| 0.6902% | |
| -21.2395% | |
| -13.086% | |
| 46.6205% | |
| -0.2823% | |
| -13.4636% | |
| 4.243% | |
| -25.7593% | |
| 15.6678% | |
| 2.4846% | |
| 8.4734% | |
| -1.6384% | |
| -2.9386% | |
| 25.5223% | |
| 8.6336% | |
| 20.7432% | |
| -4.6888% | |
| -16.8996% | |
| 18.7624% | |
| 15.2199% | |
| 3.6256% | |
| -17.5328% | |
| 2.755% | |
| 13.4504% | |
| 15.447% | |
| 4.7791% | |
| -7.2681% | |
| -0.2358% | |
| 33.0805% | |
| -27.6237% | |
| 38.7838% | |
| 4.3872% | |
| 8.8657% | |
| -11.2348% | |
| -13.7076% | |
| -12.302% | |
| 67.743% | |
| 32.7825% | |
| -5.766% | |
| 28.3977% | |
| 5.3216% | |
| -51.6178% | |
| 16.731% | |
| -22.4769% | |
| 34.1692% | |
| -24.8492% | |
| -25.0259% | |
| 4.5083% | |
| -18.6629% | |
| 2.5452% | |
| 15.3846% | |
| 29.1412% | |
| 36.256% | |
| 40.5906% | |
| 11.6543% | |
| -6.1532% | |
| 69.4243% | |
| 17.7835% | |
| -9.4271% | |
| 7.6989% | |
| -70.9269% | |
| 208.3812% | |
| -34.4482% | |
| -6.1407% | |
| -30.8067% | |
| -50.6343% | |
| -11.7066% | |
| -9.3664% | |
| 36.1044% | |
| -3.7597% | |
| 33.4014% | |
| -16.7924% | |
| -50.0395% | |
| 23.3159% | |
| 195.0735% | |
| 28.2684% | |
| 11.4589% | |
| -5.3195% | |
| 0% |